title: Biomaterial-induced sarcoma: A novel model to study preneoplastic change.
abstract: In the study of carcinogenesis most interest has focused on carcinomas, as they represent the majority of human cancers. The recognition of the adenoma-carcinoma sequence both in humans and in animal experimental models has given the field of basic oncology the opportunity to elucidate individual mechanisms in the multistep development of carcinoma. The relative scarcity of human sarcomas coupled with the lack of adequate animal models has hampered understanding of the molecular genetic steps involved. We present an experimental model in the rat in which a high incidence of malignant mesenchymal tumors arise around a subcutaneously implanted biomaterial. Nine commercially available biomaterials were implanted in a total of 490 rats of the Fischer strain for 2 years. On average, macroscopic tumors were found in 25.8% of implantation sites over a period from 26 to 110 weeks after implantation. The most frequent tumors were malignant fibrous histiocytomas and pleomorphic sarcomas, although fibrosarcomas, leiomyosarcomas, and angiosarcomas readily developed, the latter especially around polyurethane implants. Of particular interest are the results of a detailed histological study of the capsules around the implanted biomaterials without tumors. Here a spectrum of change from focal proliferative lesions through preneoplastic proliferation to incipient sarcoma could be observed. A parallel immunohistochemical study of peri-implant capsules showed that proliferating cell nuclear antigen was of particular help in identifying these atypical proliferative lesions. To our knowledge this is the first description of a sarcoma model in which preneoplastic lesions can be readily identified and also reproducibly induced. This model provides the molecular biologist with defined stages in the development of mesenchymal malignancy, with which the multistage tumorigenesis hypothesis can be tested, analogous to the well-known adenoma-carcinoma sequence.
authors.affiliation: Institute of Pathology, Johannes Gutenberg University, Mainz, Germany. kirkpatrick@pathologie.klinik.uni-mainz.de
authors.forename: C J
authors.initials: CJ
authors.lastname: Kirkpatrick
authors.forename: A
authors.initials: A
authors.lastname: Alves
authors.forename: H
authors.initials: H
authors.lastname: Köhler
authors.forename: J
authors.initials: J
authors.lastname: Kriegsmann
authors.forename: F
authors.initials: F
authors.lastname: Bittinger
authors.forename: M
authors.initials: M
authors.lastname: Otto
authors.forename: D F
authors.initials: DF
authors.lastname: Williams
authors.forename: R
authors.initials: R
authors.lastname: Eloy
mesh_terms: D000818:Animals; D001672:Biocompatible Materials; D004195:Disease Models, Animal; D004343:Drug Implants; D018219:Histiocytoma, Benign Fibrous / Q000473:pathology; D007150:Immunohistochemistry; D015994:Incidence; D011230:Precancerous Conditions / Q000473:pathology*; D051381:Rats; D011916:Rats, Inbred F344; D012513:Sarcoma, Experimental / Q000139:chemically induced* / Q000453:epidemiology / Q000378:metabolism / Q000473:pathology
chemical_list: D001672:Biocompatible Materials; D004343:Drug Implants